Europe Hiv Clinical Trials Market Size & Outlook, 2025-2030
Related Markets
Europe hiv clinical trials market highlights
- The Europe hiv clinical trials market generated a revenue of USD 305.3 million in 2024.
- The market is expected to grow at a CAGR of 5.4% from 2025 to 2030.
- In terms of segment, phase iii was the largest revenue generating phase in 2024.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 305.3 million |
| Market revenue in 2030 | USD 404.8 million |
| Growth rate | 5.4% (CAGR from 2025 to 2030) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III, Phase IV |
Other key industry trends
- In terms of revenue, Europe region accounted for 19.6% of the global hiv clinical trials market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 421.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
HIV Clinical Trials Market Scope
HIV Clinical Trials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Bionor Holding | View profile | 1-10 | Oslo, Oslo, Norway, Europe | https://bionorholding.com |
| SGS SA | View profile | - | - | - |
| Janssen | View profile | 10001+ | Beerse, Antwerpen, Belgium, Europe | https://www.janssen.com/ |
| Parexel International Corporation | View profile | - | - | - |
| Gilead Sciences, Inc. | View profile | - | - | - |
| IQVIA Inc. | View profile | - | - | - |
| PPD | View profile | 11-50 | Tunbridge Wells, Kent, United Kingdom, Europe | https://ppdukltd.com/ |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
Europe hiv clinical trials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hiv clinical trials market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 46.12% in 2024. Horizon Databook has segmented the Europe hiv clinical trials market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Europe hiv clinical trials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe hiv clinical trials market databook
-
Our clientele includes a mix of hiv clinical trials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe hiv clinical trials market , including forecasts for subscribers. This continent databook contains high-level insights into Europe hiv clinical trials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe hiv clinical trials market size, by country, 2018-2030 (US$M)
Europe HIV Clinical Trials Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
